Multidisciplinary Research to Accelerate Hepatitis B Cure in Persons Living with HIV and HBV (MRA-HBV)

Summary

The National Institutes of Health (NIH) is forecasting a funding opportunity for multidisciplinary research aimed at accelerating a cure for Hepatitis B (HBV) in persons who are co-infected with HIV and HBV. The opportunity is identified under number FOR-AI-27-017 and is currently in a forecasted/pre-announcement status. No further scope, budget, or submission details are available from the posted notice at this time.

Risks & flags

• Opportunity is only a forecast — no full solicitation text available, making it impossible to assess wiring, evaluation criteria, or incumbent advantage at this stage.
• No budget, period of performance, eligibility requirements, or submission details are disclosed in the notice.